Funded Tech Companies

Endeavor BioMedicines

Endeavor BioMedicines, operating out of Solana Beach, received equity investments through Fidelity Management & Research Company, Symbiosis and Invus.

Company Overview

Contact Information

Company Background Information

Overview

Endeavor BioMedicines is developing new treatments targeting the underlying causes of pulmonary fibrosis. The company is developing taladegib, a small-molecule inhibitor of the Hedgehog signaling pathway, that is being investigated for the treatment of idiopathic pulmonary fibrosis (IPF).

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/24/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Hood

        

Chief Financial Officer

Raghu Saripalli

        

Chief Scientific Officer

Miguel De Los Rios

        

Company Investors

• Fidelity Management & Research Company
• Symbiosis
• Invus
• Ally Bridge Group
• Abrdn
• Avidity Partners
• Piper Heartland
• Omega Funds (Bernard Davitian)
• Longitude Capital Management (Sandip Agarwala)
• Eckuity Capital
• Velosity Capital
• Matrix Capital Management
• Perceptive Advisors
• T. Rowe Price
• Woodline Partners

Browse more funded tech companies:

Endeavor | Endeca Technologies

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary